Veterinary Cannabidiol (CBD) Market
By Product;
Food-Grade, Therapeutic-Grade and Personal CareBy Distribution Channel;
E-Commerce, Retail Pharmacies and Vet Care ClinicsBy Source;
Marijuana-Derived and Hemp-DerivedBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Veterinary Cannabidiol (CBD) Market Overview
Veterinary Cannabidiol (CBD) Market (USD Million)
Veterinary Cannabidiol (CBD) Market was valued at USD 205.25 million in the year 2024. The size of this market is expected to increase to USD 3,539.79 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 50.2%.
Veterinary Cannabidiol (CBD) Market
*Market size in USD million
CAGR 50.2 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 50.2 % |
| Market Size (2024) | USD 205.25 Million |
| Market Size (2031) | USD 3,539.79 Million |
| Market Concentration | Low |
| Report Pages | 336 |
Major Players
- Honest Paws
- HolistaPet
- HempMy Pet
- Canna-Pet
- Joy Organics
- Fomo Bones
- Pet Releaf
- Green Roads of Florida
- Wet Noses
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Veterinary Cannabidiol (CBD) Market
Fragmented - Highly competitive market without dominant players
Veterinary Cannabidiol (CBD) Market is witnessing strong momentum as pet owners increasingly adopt natural solutions for animal health. Over 55% of pet owners now express interest in CBD-based treatments, largely due to their effectiveness in addressing pain, inflammation, anxiety, and seizures in companion animals. This trend reflects a growing trust in CBD as a reliable and holistic therapeutic option.
Growing Preference for Natural Remedies
The rising inclination toward plant-based therapies has positioned CBD as a top choice in veterinary care. Research highlights that nearly 50% of pet care consumers now prefer natural alternatives over conventional drugs. With its proven ability to support preventive health and manage chronic issues, veterinary CBD is becoming a cornerstone of modern animal wellness practices.
Rising Expenditure on Pet Healthcare
Increasing pet healthcare spending is fueling the adoption of CBD-infused products across the industry. Surveys reveal that around 60% of pet owners are willing to invest in advanced care solutions that enhance the overall well-being of their pets. This willingness to spend more is encouraging the development of premium CBD oils, treats, and supplements, designed for ease of use and maximum therapeutic impact.
Innovations Driving Market Expansion
Continuous research and innovation are shaping the growth of this market, with nearly 40% of new veterinary supplements integrating CBD as a key ingredient. Enhanced formulations, precise dosing mechanisms, and extended-release products are boosting both safety and efficacy. These innovations not only improve treatment outcomes but also broaden the spectrum of veterinary CBD applications.
Future Growth Opportunities
The veterinary CBD market holds strong growth potential, backed by rising consumer awareness, greater acceptance by veterinarians, and expanding product pipelines. Reports indicate that more than 45% of veterinarians now recommend CBD as part of integrated pet care strategies. This expanding endorsement highlights CBD’s path toward becoming a mainstream solution in veterinary medicine.
Veterinary Cannabidiol (CBD) Market Key Takeaways
-
The trend of pet humanisation is driving demand for veterinary CBD products as pet owners seek natural alternatives for managing anxiety, joint pain and mobility issues in companion animals.
-
Multi-format innovations such as oils, chews, topicals and treats tailored for cats, dogs and equines are expanding the addressable market and improving dosing flexibility across species.
-
The market remains constrained by regulatory ambiguity—limited approvals, varying claims rules and import/sourcing hurdles require careful compliance to build trust with veterinarians and pet owners.
-
Digital channels dominate—online sales, auto-ship and subscription programs lower friction for first-time buyers and support recurring purchase behaviour among wellness-focused demographics.
-
Regional dynamics—North America leads on premium spend and product availability, while Asia-Pacific is emerging quickly with rising disposable incomes and growing demand for pet wellness solutions.
-
Quality and credibility are pivotal: brands that provide third-party testing, transparent ingredient sourcing and evidence-based benefits are accelerating clinical acceptance in the veterinary channel.
-
Strategic differentiation comes from veterinary partnerships, clinically-oriented positioning and ecosystem models (device/delivery plus monitoring) that elevate outcomes and capture higher-value niches.
Veterinary Cannabidiol (CBD) Market Recent Developments
-
In February 2022, a veterinary wellness brand secured an investment round to expand CBD formulations and clinical evidence programs for companion animals.
-
In June 2023, two pet-care companies announced a collaboration to co-develop veterinarian-dispensed CBD chews with standardized cannabinoid profiles.
Veterinary Cannabidiol (CBD) Market Segment Analysis
In this report, the Veterinary Cannabidiol (CBD) Market has been segmented by Product, Distribution Channel, Source, and Geography.
Veterinary Cannabidiol (CBD) Market, Segmentation by Product
The Product segmentation outlines the different types of cannabidiol (CBD) products used for veterinary purposes. These products cater to various applications, such as pet wellness, therapeutic treatments, and personal care, depending on the needs of animals and pet owners.
Food-Grade
Food-Grade CBD products are designed for consumption by animals, such as dogs, cats, and other pets. These products include CBD-infused treats, oils, and powders that support wellness and address conditions like anxiety, pain, and inflammation in animals.
Therapeutic-Grade
Therapeutic-Grade CBD products are used for medical treatments in animals, often prescribed to treat specific conditions such as joint pain, seizures, and anxiety. These products are typically formulated with higher concentrations of CBD and are used under veterinary supervision.
Personal Care
Personal Care products include CBD-infused grooming items such as shampoos, sprays, and balms. These products are designed to improve the overall well-being and skin health of pets, helping with issues like itching, inflammation, and coat condition.
Veterinary Cannabidiol (CBD) Market, Segmentation by Distribution Channel
The Distribution Channel segmentation outlines the various platforms through which veterinary CBD products are sold. These channels play a crucial role in ensuring that pet owners and veterinary professionals have access to the right CBD products for animals.
E-Commerce
E-Commerce is a rapidly growing distribution channel for veterinary CBD products, offering convenience and accessibility to pet owners. Online platforms provide a wide range of products, often with detailed information, reviews, and the ability to compare various options.
Retail Pharmacies
Retail Pharmacies are a key distribution channel for over-the-counter veterinary CBD products. Pet owners can find CBD-based treatments and wellness products in pharmacies, offering both convenience and trust due to established relationships with healthcare professionals.
Vet Care Clinics
Vet Care Clinics provide CBD products directly to pet owners as part of comprehensive veterinary care. Many clinics offer therapeutic-grade CBD products under the guidance of veterinarians, ensuring proper dosing and treatment plans tailored to the animal’s condition.
Veterinary Cannabidiol (CBD) Market, Segmentation by Source
The Source segmentation focuses on the origins of the cannabidiol used in veterinary products. The source of CBD plays a key role in product formulations, affecting the legal status, potency, and potential benefits of the product.
Marijuana-Derived
Marijuana-Derived CBD is sourced from cannabis plants that contain higher levels of tetrahydrocannabinol (THC). This type of CBD is typically used in therapeutic-grade products and is regulated more strictly due to the presence of THC, which has psychoactive effects. It is more commonly used in regions where cannabis laws allow its use.
Hemp-Derived
Hemp-Derived CBD is extracted from hemp plants, which contain lower levels of THC and are legal in many regions. This type of CBD is widely used in food-grade and personal care products for animals, offering a non-psychoactive alternative that is safe and effective for general wellness and therapeutic purposes.
Veterinary Cannabidiol (CBD) Market, Segmentation by Geography
The Geography segmentation highlights the regional demand for veterinary CBD products, influenced by local regulations, cultural factors, and the adoption of CBD-based treatments in veterinary practices across different regions.
Regions and Countries Analyzed in this Report
North America
North America is the leading market for veterinary cannabidiol products, driven by a strong pet care industry, increasing pet ownership, and evolving attitudes towards alternative pet health treatments. The U.S. market is expanding rapidly due to growing acceptance of CBD-based products for pets and ongoing legalization efforts surrounding cannabis.
Europe
Europe has a significant and growing market for veterinary CBD products, with increasing regulatory approvals and rising awareness of the therapeutic benefits of CBD for pets. Countries like Germany, the UK, and France are leading the market, supported by pet owners seeking natural solutions for animal health.
Asia Pacific
Asia Pacific is experiencing rapid growth in the veterinary CBD market, particularly in regions like Australia and Japan, where pet ownership is on the rise and demand for holistic pet care products is growing. Regulatory challenges and varying legal frameworks are influencing the market development in this region.
Middle East & Africa
Middle East & Africa is an emerging market for veterinary CBD products, with gradual adoption in countries like the UAE and South Africa. As awareness of the benefits of CBD in pet health increases, the market is expected to expand as healthcare infrastructure improves in the region.
Latin America
Latin America is gradually adopting veterinary CBD products, particularly in Brazil and Mexico. Increasing awareness and growing access to cannabis-based products for pets are expected to drive market growth, supported by evolving pet care practices and improved regulatory environments.
Veterinary Cannabidiol (CBD) Market Forces
This report provides an in depth analysis of various factors that impact the dynamics of Veterinary CBD Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints, and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development | |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers:
- Increasing Pet Wellness Awareness
- Growing Acceptance of CBD Products
-
Rising Veterinary Recommendations - veterinary CBD market is witnessing a significant surge, driven by increasing recommendations from veterinarians. As more research emerges highlighting the potential benefits of CBD in managing various health conditions in animals, veterinarians are increasingly integrating CBD into their treatment protocols. This shift is particularly notable in managing issues like pain, anxiety, inflammation, and seizures in pets. With pet owners showing a growing interest in natural and holistic approaches to pet care, CBD products are gaining traction as viable alternatives to traditional pharmaceuticals.
The legalization of CBD in several regions has further propelled market growth, fostering innovation and the development of a diverse range of CBD-infused products specifically tailored for pets. Veterinary clinics and pet stores are increasingly stocking CBD products, catering to the rising demand from pet owners seeking safe and effective solutions for their furry companions' health and well-being. As regulatory frameworks continue to evolve and consumer awareness regarding CBD expands, the veterinary CBD market is poised for continued expansion in the coming years.
Restraints:
- Regulatory Uncertainties
- Limited Clinical Evidence
-
Concerns Over Product Quality and Safety - veterinary CBD market is witnessing significant growth, driven by increasing consumer demand for alternative therapies for pets' ailments. However, this burgeoning market is also accompanied by concerns over the quality and safety of CBD products intended for animal use.
Regulatory oversight varies widely across regions, leading to inconsistencies in product quality standards and labeling practices. This lack of uniformity raises apprehensions among pet owners regarding the reliability and effectiveness of CBD products for their beloved companions. Moreover, the absence of comprehensive testing protocols and standardized dosing guidelines further compounds these concerns, leaving both veterinarians and consumers uncertain about the optimal use of CBD in veterinary medicine.
Opportunities:
- Expanding Product Portfolio
- Emerging Markets Adoption
-
Collaborations with Veterinary Professionals - In the burgeoning global market for veterinary CBD products, collaborations with veterinary professionals have emerged as pivotal initiatives. These partnerships facilitate a deeper understanding of the potential benefits and risks associated with CBD use in animals. Through collaborative efforts, veterinarians can contribute their clinical expertise, offering insights into dosage, efficacy, and potential interactions with other medications. This collaboration ensures that CBD products are developed and administered in a manner that prioritizes animal welfare and aligns with established veterinary practices.
Collaborations between CBD manufacturers and veterinary professionals play a crucial role in advancing research in this field. By combining resources and expertise, these partnerships can support clinical trials and studies aimed at elucidating the therapeutic effects of CBD on various animal species. Through rigorous scientific inquiry, veterinarians and researchers can generate evidence-based guidelines for the use of CBD in veterinary medicine, fostering confidence among pet owners and regulatory bodies. Ultimately, these collaborations drive innovation and contribute to the responsible and ethical integration of CBD products into veterinary care.
Veterinary Cannabidiol (CBD) Market Competitive Landscape Analysis
Veterinary Cannabidiol (CBD) Market is witnessing increased competition as manufacturers refine their strategies to meet rising demand across companion and livestock care. Intense collaboration and emerging partnerships among producers, distributors, and research groups fuel sector growth. Companies focus on differentiated product profiles, premium formulations, and veterinary endorsement to secure sustainable market positioning.
Market Structure and Concentration
The market shows a mix of specialized players and emerging entrants, creating a moderately fragmented structure. Top participants control significant percentages (%) through targeted merger activities and exclusive distribution agreements. Smaller firms leverage niche innovation and agility to compete effectively, while well-established brands expand their influence through diversified product portfolios and long-term supply partnerships.
Brand and Channel Strategies
Leading companies strengthen brand presence by optimizing retail and digital channels, enhancing customer trust, and fostering veterinary recommendations. Strong strategies in e-commerce and specialized pet health stores help boost accessibility and visibility. Promotional collaborations with clinics and training programs for professionals create deeper end-user confidence, further propelling competitive growth.
Innovation Drivers and Technological Advancements
Continuous product innovation shapes market competitiveness as companies introduce improved CBD delivery methods and precise dosage technologies. Advanced extraction techniques and enhanced technological advancements ensure better safety and efficacy profiles. Partnerships between research institutions and producers accelerate product approvals and increase the pace of differentiation, supporting ongoing market expansion.
Regional Momentum and Expansion
Regional leaders drive competitive influence by adapting to varying veterinary regulations and pet care trends. Aggressive expansion into fast-growing areas through joint ventures and strategic collaboration increases market penetration. Tailored formulations and specialized distribution networks strengthen brand positioning, while localized strategies build resilience against regulatory and competitive pressures.
Future Outlook
The competitive landscape is set for accelerated growth as more players invest in advanced research and innovative marketing models. Continued partnerships between technology providers and veterinary networks will refine supply chains and product credibility. Market leaders aim to expand their reach by embracing evolving regulations and strengthening long-term strategies that enhance competitiveness and trust.
Key players in Veterinary Cannabidiol (CBD) Market include:
- Charlotte’s Web Holdings, Inc.
- CBDfx
- Holistapet
- Canna-Pet
- Pet Releaf
- Honest Paws
- Joy Organics
- HempMy Pet
- Green Roads of Florida
- Fomo Bones
- Wet Noses
- Naturecan Pets
- Elixinol Wellness Limited
- Pawell
- CannPal Animal Therapeutics
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Source
- Market Snapshot, By Region
- Veterinary Cannabidiol (CBD) Market Forces
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Pet Wellness Awareness
- Growing Acceptance of CBD Products
- Rising Veterinary Recommendations
- Restraints
- Regulatory Uncertainties
- Limited Clinical Evidence
- Concerns Over Product Quality and Safety
- Opportunities
- Expanding Product Portfolio
- Emerging Markets Adoption
- Collaborations with Veterinary Professionals
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Veterinary Cannabidiol (CBD) Market, By Product, 2021 - 2031 (USD Million)
- Food-Grade
- Therapeutic-Grade
- Personal Care
- Veterinary Cannabidiol (CBD) Market, By Distribution Channel, 2021 - 2031 (USD Million)
- E-Commerce
- Retail Pharmacies
- Vet Care Clinics
- Veterinary Cannabidiol (CBD) Market, By Source, 2021 - 2031 (USD Million)
- Marijuana-Derived
- Hemp-Derived
- Veterinary Cannabidiol (CBD) Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Veterinary Cannabidiol (CBD) Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Charlotte’s Web Holdings, Inc.
- CBDfx
- Holistapet
- Canna-Pet
- Pet Releaf
- Honest Paws
- Joy Organics
- HempMy Pet
- Green Roads of Florida
- Fomo Bones
- Wet Noses
- Naturecan Pets
- Elixinol Wellness Limited
- Pawell
- CannPal Animal Therapeutics
- Company Profiles
- Analyst Views
- Future Outlook of the Market

